Ledger.Open graph →
SEC Form D · filed October 24, 2019

Blade Therapeutics, Inc

Offering
$24.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

M. S. Chiang · South San Francisco, CAExecWilliam V. Slattery · South San Francisco, CADirectorPrabha S. Ibrahim · South San Francisco, CAExecRana R. Al-Hallaq · South San Francisco, CADirectorPeter V. Van Vlasselaer · South San Francisco, CADirectorLloyd B. Klickstein · South San Francisco, CADirectorWendye R. Robbins · South San Francisco, CAExec · DirectorGary B. Patou · South San Francisco, CAExecLuke S. Evnin · South San Francisco, CADirectorCameron V. Wheeler · South San Francisco, CADirectorJames B. Scopa · South San Francisco, CADirectorMark Blaufuss · Twinsburg, OHExecDimitar S. Baronov · Boston, MADirectorTrevor G. Campion · Chicago, ILDirectorHeinz Sohm · MIAMI, FLExecDavid S. Shepherd · Boston, MADirectorAndres Cohen · MIAMI, FLDirectorEvan Butler · Boston, MADirectorGregory S. Martin · Boston, MADirectorShane Cooke · Boston, MAExec · DirectorGuy L. Fish · Boston, MADirectorRichard G. Parker · Chicago, ILExecBrett Baker · Bozeman, MTExecJason Harmon · Bozeman, MTDirectorJarret Sha · Bozeman, MTDirectorKaley Wilson · Bozeman, MTExecKarim Lalji · Bozeman, MTDirectorJennifer A. Keen · St Helier, Y9DirectorKeith C. Mallet · St Helier, Y9DirectorDaryl J. Pilcher · St Helier, Y9DirectorRay Sturm · San Francisco, CAExec · DirectorHoward Michalski · PORTLAND, ORDirectorCraig Froude · PORTLAND, ORExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗